Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Verona Pharma PLC

www.veronapharma.com

Latest From Verona Pharma PLC

The Many Paths To Biotech CEO

There is no single path toward becoming a CEO. The job requires many different skills, often concurrently: sharp analytical capabilities, strategic thinking, clear communication with multiple audiences, curiosity and perseverance. It demands strong leadership but also humility, and a willingness to acknowledge mistakes and knowledge gaps.

C-Suite Speaks Business Strategies

Verona Investors Gasp As Lead Asset Misses Main Endpoint In COPD Trial

Verona’s shares sank after a brief three-day Phase II trial using lead asset RPL554 in patients already maximally bronchodilated on both a LAMA and LABA missed the primary endpoint.

Clinical Trials Respiratory

Under The Radar: Potential Small Cap Takeover Targets

Looking back at the second quarter, PharmaVitae analysts have selected 10 biopharma companies with market caps under $3bn they think are primed for acquisition – and the likely candidates for a buy-out.

M & A StartUps and SMEs

Bye Bye Vernalis And Another Blow For UK Biotech

Vernalis' decision to switch strategy and enter the US cough-cold market backfired spectacularly and acquirer Ligand is getting hold of what once was a jewel in the UK biotech crown for next to nothing.

M & A Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Inflammation
  • Respiratory, Pulmonary
  • Alias(es)
  • Isis Resources PLC
  • Rhinopharma
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Verona Pharma PLC
  • Senior Management
  • Jan-Anders Karlsson, PhD, CEO
    Piers Morgan, CFO
    Nina Church, Executive Dir., Global Clinical Dev.
    Nancy Herje, Sr. Dir., Clinical Operations
  • Contact Info
  • Verona Pharma PLC
    Phone: (44) (0)203 283 4200
    3 More London Riverside
    London, SE1 2RE
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register